PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23665489-3 2013 beta-PEA, d-amphetamine, MDMA, cathinone and methylphenidate caused concentration-dependent contractions of rat isolated aortic rings which were unaffected by prazosin (1 muM), ICI-118,551 (1 muM), cocaine (10 muM) and pargyline (10 muM), to inhibit alpha1- and beta2-adrenoceptors, neuronal transport and monoamine oxidase (MAO), respectively. phenethylamine 0-8 monoamine oxidase A Rattus norvegicus 306-323 23665489-3 2013 beta-PEA, d-amphetamine, MDMA, cathinone and methylphenidate caused concentration-dependent contractions of rat isolated aortic rings which were unaffected by prazosin (1 muM), ICI-118,551 (1 muM), cocaine (10 muM) and pargyline (10 muM), to inhibit alpha1- and beta2-adrenoceptors, neuronal transport and monoamine oxidase (MAO), respectively. phenethylamine 0-8 monoamine oxidase A Rattus norvegicus 325-328 19883764-8 2010 Compared with human MAO A, rat MAO A oxidizes serotonin or kynuramine with twofold higher k(cat)/K(m) values, oxidizes phenethylamine with a 6.7-fold higher catalytic efficiency and benzylamine with a approximately 40-fold higher catalytic efficiency. phenethylamine 119-133 monoamine oxidase A Rattus norvegicus 31-36 20406628-0 2010 Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine. phenethylamine 158-179 monoamine oxidase A Rattus norvegicus 24-29 20406628-11 2010 Our results suggest that the combined treatment with a MAO-A inhibitor and a MAO-B inhibitor strengthens antidepressant effects because the combined treatment increases extracellular noradrenaline levels more than a MAO-A inhibitor alone through increases in beta-phenylethylamine. phenethylamine 259-280 monoamine oxidase A Rattus norvegicus 55-60 15351283-1 2004 A simple and selective assay for the evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors was developed through the simultaneous determination of endogenous 5-hydroxy tryptamine, 5-hydroxyindole-3-acetic acid (5-HIAA), tryptophane, and 2-phenethylamine (PEA) in rat brain using liquid chromatography-tandem mass spectrometry (LC/MS/MS). phenethylamine 304-320 monoamine oxidase A Rattus norvegicus 83-115 19198157-2 2008 It has been established that MAO of mink, like MAO of rat, has properties of classic mammalian MAO: it deaminates tyramine, tryptamine, serotonin, benzilamine, beta-phenylethylamine and does not deaminate histamine as well as does not have sensitivity to semicarbazide. phenethylamine 160-181 monoamine oxidase A Rattus norvegicus 29-32 19198157-2 2008 It has been established that MAO of mink, like MAO of rat, has properties of classic mammalian MAO: it deaminates tyramine, tryptamine, serotonin, benzilamine, beta-phenylethylamine and does not deaminate histamine as well as does not have sensitivity to semicarbazide. phenethylamine 160-181 monoamine oxidase A Rattus norvegicus 47-50 19198157-2 2008 It has been established that MAO of mink, like MAO of rat, has properties of classic mammalian MAO: it deaminates tyramine, tryptamine, serotonin, benzilamine, beta-phenylethylamine and does not deaminate histamine as well as does not have sensitivity to semicarbazide. phenethylamine 160-181 monoamine oxidase A Rattus norvegicus 47-50 15351283-1 2004 A simple and selective assay for the evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors was developed through the simultaneous determination of endogenous 5-hydroxy tryptamine, 5-hydroxyindole-3-acetic acid (5-HIAA), tryptophane, and 2-phenethylamine (PEA) in rat brain using liquid chromatography-tandem mass spectrometry (LC/MS/MS). phenethylamine 304-320 monoamine oxidase A Rattus norvegicus 103-106 15351283-1 2004 A simple and selective assay for the evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors was developed through the simultaneous determination of endogenous 5-hydroxy tryptamine, 5-hydroxyindole-3-acetic acid (5-HIAA), tryptophane, and 2-phenethylamine (PEA) in rat brain using liquid chromatography-tandem mass spectrometry (LC/MS/MS). phenethylamine 322-325 monoamine oxidase A Rattus norvegicus 83-115 15351283-1 2004 A simple and selective assay for the evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors was developed through the simultaneous determination of endogenous 5-hydroxy tryptamine, 5-hydroxyindole-3-acetic acid (5-HIAA), tryptophane, and 2-phenethylamine (PEA) in rat brain using liquid chromatography-tandem mass spectrometry (LC/MS/MS). phenethylamine 322-325 monoamine oxidase A Rattus norvegicus 103-106 11245847-3 2001 Immunoblots and enzyme assays, performed using [14C]5-hydroxytriptamine and [14C]beta-phenylethylamine as substrates for monoamine oxidases-A and -B, respectively, showed that monoamine oxidase-A is the isoenzyme largely predominant in 9-day-old rats renal cortex. phenethylamine 81-102 monoamine oxidase A Rattus norvegicus 121-148 12818349-3 2003 We thought worthwide to evaluate the effect of Ro 41-1049 and lazabemide, both members of a class of highly selective, mechanism-based and reversible inhibitors for MAO-A and MAO B, respectively on the metabolization of beta-PEA by the rat heart. phenethylamine 220-228 monoamine oxidase A Rattus norvegicus 165-170 12818349-6 2003 Unexpectedly, the selective MAO-A inhibitor Ro 41-1049 was by far the most potent inhibitor of beta-PEA (20 microM) deamination in the rat heart, while clorgyline, another MAO A inhibitor, and lazabemide, a MAO B inhibitor, had intermediate efficacy; selegiline was found unable to inhibit deamination of beta-PEA. phenethylamine 95-103 monoamine oxidase A Rattus norvegicus 28-33 12818349-6 2003 Unexpectedly, the selective MAO-A inhibitor Ro 41-1049 was by far the most potent inhibitor of beta-PEA (20 microM) deamination in the rat heart, while clorgyline, another MAO A inhibitor, and lazabemide, a MAO B inhibitor, had intermediate efficacy; selegiline was found unable to inhibit deamination of beta-PEA. phenethylamine 305-313 monoamine oxidase A Rattus norvegicus 28-33 11245847-3 2001 Immunoblots and enzyme assays, performed using [14C]5-hydroxytriptamine and [14C]beta-phenylethylamine as substrates for monoamine oxidases-A and -B, respectively, showed that monoamine oxidase-A is the isoenzyme largely predominant in 9-day-old rats renal cortex. phenethylamine 81-102 monoamine oxidase A Rattus norvegicus 176-195 9610921-4 1998 In an attempt to determine some of the biochemical changes in striatal dopaminergic neurotransmission that could contribute to REM sleep deprivation effects, we measured the activity of monoamine oxidase (MAO) A and B, the enzymes responsible for dopamine and beta-phenylethylamine (beta-PEA) deamination in striatum. phenethylamine 260-281 monoamine oxidase A Rattus norvegicus 186-217 10504491-3 1999 METHODS: MAOs were characterized in membrane preparations and intact mesangial cells by enzyme assay using [14C]5-hydroxytryptamine and [14C]beta-phenylethylamine as specific substrates for MAO-A and MAO-B, respectively, and by Western blot analysis. phenethylamine 141-162 monoamine oxidase A Rattus norvegicus 190-195 10897801-4 1999 MAO-A and MAO-B activities were estimated with radioassays employing serotonin and beta-phenylethylamine, respectively and specific inhibitors, clorgyline and deprenyl. phenethylamine 83-104 monoamine oxidase A Rattus norvegicus 0-5 9610921-4 1998 In an attempt to determine some of the biochemical changes in striatal dopaminergic neurotransmission that could contribute to REM sleep deprivation effects, we measured the activity of monoamine oxidase (MAO) A and B, the enzymes responsible for dopamine and beta-phenylethylamine (beta-PEA) deamination in striatum. phenethylamine 283-291 monoamine oxidase A Rattus norvegicus 186-217 8333043-9 1993 In the transplanted liver, the activity of MAO with 5-HT and 2-phenylethylamine was increased by 26% (P < 0.05) and by 53% (P < 0.001), respectively. phenethylamine 61-79 monoamine oxidase A Rattus norvegicus 43-46 8138017-2 1993 Lipid peroxidation (LPO) in rat liver mitochondria decreased the activity of monoamine oxidase (MAO) with physiological substrates serotonin and 2-phenylethylamine (by 15-30%) and induced deamination of glucosamine, which was highly sensitive to selective MAO A inhibitor pirlindole. phenethylamine 145-163 monoamine oxidase A Rattus norvegicus 77-94 8138017-2 1993 Lipid peroxidation (LPO) in rat liver mitochondria decreased the activity of monoamine oxidase (MAO) with physiological substrates serotonin and 2-phenylethylamine (by 15-30%) and induced deamination of glucosamine, which was highly sensitive to selective MAO A inhibitor pirlindole. phenethylamine 145-163 monoamine oxidase A Rattus norvegicus 96-99 3961266-3 1986 PPA was found to inhibit both human brain and rat liver mitochondrial MAO activities in vitro, i.e. Ki"s were 150 microM and 800 microM with respect to serotonin (Type A substrate) and beta-phenylethylamine (Type B substrate). phenethylamine 185-206 monoamine oxidase A Rattus norvegicus 70-73 2251787-2 1990 It was shown that in experimental catatonia (as compared with rats of the corresponding control group) there was a dramatic increase in the brain stem of the rate of oxidative deamination of beta-phenylethylamine catalyzed by MAO-III; there was also a statistically significant (albeit less expressed than in the experiments with beta-phenylethylamine) increase in the rate of deamination of tyramine and a decrease in the rate of deamination of serotonin. phenethylamine 191-212 monoamine oxidase A Rattus norvegicus 226-229 2251787-2 1990 It was shown that in experimental catatonia (as compared with rats of the corresponding control group) there was a dramatic increase in the brain stem of the rate of oxidative deamination of beta-phenylethylamine catalyzed by MAO-III; there was also a statistically significant (albeit less expressed than in the experiments with beta-phenylethylamine) increase in the rate of deamination of tyramine and a decrease in the rate of deamination of serotonin. phenethylamine 330-351 monoamine oxidase A Rattus norvegicus 226-229 2251787-3 1990 In the systems with MAO-II beta we detected statistically significant increase in the rates of deamination of tyramine and beta-phenylethylamine in experimental catatonia as compared with corresponding control. phenethylamine 123-144 monoamine oxidase A Rattus norvegicus 20-23 8242685-19 1993 The parallels between effects of increased 2-phenylethylamine availability and effects of administration of MAO inhibitor antidepressants on catecholamine receptor systems indicate that this substrate for MAO may mediate some of the effects of MAO inhibitor antidepressants. phenethylamine 43-61 monoamine oxidase A Rattus norvegicus 205-208 8242685-19 1993 The parallels between effects of increased 2-phenylethylamine availability and effects of administration of MAO inhibitor antidepressants on catecholamine receptor systems indicate that this substrate for MAO may mediate some of the effects of MAO inhibitor antidepressants. phenethylamine 43-61 monoamine oxidase A Rattus norvegicus 205-208 1601056-2 1992 Since monoamine oxidase (MAO) was not inhibited during the assay, the [3H]2-phenylethylamine binding may have been affected by an interaction between 2-phenylethylamine and the enzyme. phenethylamine 74-92 monoamine oxidase A Rattus norvegicus 6-23 1601056-2 1992 Since monoamine oxidase (MAO) was not inhibited during the assay, the [3H]2-phenylethylamine binding may have been affected by an interaction between 2-phenylethylamine and the enzyme. phenethylamine 74-92 monoamine oxidase A Rattus norvegicus 25-28 1700071-7 1990 However, the relatively selective MAO-B substrate beta-phenylethylamine (PEA) was also oxidized, showing that these cultures also contained MAO-B activity; the Km values for MAO-A oxidation of 5-HT and MAO-B oxidation of PEA were 135 and 45 microM, and Vmax values were 88 and 91 nmol/mg of total cell protein/h, respectively. phenethylamine 50-71 monoamine oxidase A Rattus norvegicus 174-179 1700071-7 1990 However, the relatively selective MAO-B substrate beta-phenylethylamine (PEA) was also oxidized, showing that these cultures also contained MAO-B activity; the Km values for MAO-A oxidation of 5-HT and MAO-B oxidation of PEA were 135 and 45 microM, and Vmax values were 88 and 91 nmol/mg of total cell protein/h, respectively. phenethylamine 73-76 monoamine oxidase A Rattus norvegicus 174-179 1700071-8 1990 Higher concentrations of PEA (greater than 20 microM) were oxidized by both MAO-A and MAO-B isozymes. phenethylamine 25-28 monoamine oxidase A Rattus norvegicus 76-81 3125369-2 1987 Monoamine oxidase (MAO) activities in the heart, lung and liver mitochondria decreased rapidly to about 50% those of the control rats with 5-HT and beta-phenylethylamine (beta-PEA) as substrates on the first day. phenethylamine 148-169 monoamine oxidase A Rattus norvegicus 0-17 3125369-2 1987 Monoamine oxidase (MAO) activities in the heart, lung and liver mitochondria decreased rapidly to about 50% those of the control rats with 5-HT and beta-phenylethylamine (beta-PEA) as substrates on the first day. phenethylamine 148-169 monoamine oxidase A Rattus norvegicus 19-22 3125369-2 1987 Monoamine oxidase (MAO) activities in the heart, lung and liver mitochondria decreased rapidly to about 50% those of the control rats with 5-HT and beta-phenylethylamine (beta-PEA) as substrates on the first day. phenethylamine 171-179 monoamine oxidase A Rattus norvegicus 0-17 3125369-2 1987 Monoamine oxidase (MAO) activities in the heart, lung and liver mitochondria decreased rapidly to about 50% those of the control rats with 5-HT and beta-phenylethylamine (beta-PEA) as substrates on the first day. phenethylamine 171-179 monoamine oxidase A Rattus norvegicus 19-22 3125369-9 1987 MAO activities in liver also were inhibited by adding all the cytosols when beta-PEA was the substrate, but on the contrary, lung MAO activities were increased when 5-HT was the substrate. phenethylamine 76-84 monoamine oxidase A Rattus norvegicus 0-3 6625963-4 1983 The increase in MAO activity could be explained by the observed significant decrease in apparent Km values for the amine (phenethylamine) studied. phenethylamine 122-136 monoamine oxidase A Rattus norvegicus 16-19 3835805-1 1985 In experiments on male Wistar albino rats was studied the effect of Co, Cd, Ni, Zn, Hg and Pb on the activity of rat liver and brain monoamine oxidase (MAO) using tyramine, serotonin and beta-phenylethylamine as substrates. phenethylamine 187-208 monoamine oxidase A Rattus norvegicus 133-150 3835805-1 1985 In experiments on male Wistar albino rats was studied the effect of Co, Cd, Ni, Zn, Hg and Pb on the activity of rat liver and brain monoamine oxidase (MAO) using tyramine, serotonin and beta-phenylethylamine as substrates. phenethylamine 187-208 monoamine oxidase A Rattus norvegicus 152-155 6518192-1 1984 The values of Km and V for serotonin, tyramine and beta-phenylethylamine deamination by solubilized and partially purified preparations of monoamine oxidase (MAO) from rat liver were determined. phenethylamine 51-72 monoamine oxidase A Rattus norvegicus 139-156 6518192-1 1984 The values of Km and V for serotonin, tyramine and beta-phenylethylamine deamination by solubilized and partially purified preparations of monoamine oxidase (MAO) from rat liver were determined. phenethylamine 51-72 monoamine oxidase A Rattus norvegicus 158-161 3953019-1 1986 Activity of monoamine oxidases (MAO) of the types A and B (substrates: 5-hydroxytryptamine, 2-phenylethylamine, tyramine) has been studied in mitochondrial fractions from brain, heart, liver and kidney of 24-week-old rats of the normotonic strain Wistar Kyoto (WKY) and spontaneously hypertonic rats (SHR). phenethylamine 92-110 monoamine oxidase A Rattus norvegicus 12-30 3953019-1 1986 Activity of monoamine oxidases (MAO) of the types A and B (substrates: 5-hydroxytryptamine, 2-phenylethylamine, tyramine) has been studied in mitochondrial fractions from brain, heart, liver and kidney of 24-week-old rats of the normotonic strain Wistar Kyoto (WKY) and spontaneously hypertonic rats (SHR). phenethylamine 92-110 monoamine oxidase A Rattus norvegicus 32-35 3953019-5 1986 In kidney mitochondria of SHR the activity of MAO (substrates: 5-hydroxytryptamine, 2-phenylethylamine, tyramine) did not exhibit any alterations as compared with the control WKY rats. phenethylamine 84-102 monoamine oxidase A Rattus norvegicus 46-49 3999927-6 1985 Although a high microvessel MAO activity (2.2 +/- 0.3 nmol min-1 mg prot.-1) was found using noradrenaline as substrate, significantly higher rates were found with tyramine, serotonin and beta-phenyl-ethylamine. phenethylamine 188-210 monoamine oxidase A Rattus norvegicus 28-31 6741571-3 1984 The increase in MAO activity in the presence of human plasma can be explained by the observed decrease in the apparent Km for the amine (tyramine, PEA). phenethylamine 147-150 monoamine oxidase A Rattus norvegicus 16-19 6649522-3 1983 In human placenta and rat heart containing only the type A MAO, which catalyzes deamination of 2-phenylethylamine, pyrazidol also inhibited the deamination of serotonin, tyramine and 2-phenylethylamine at comparatively low concentrations and in equal degree. phenethylamine 95-113 monoamine oxidase A Rattus norvegicus 59-62 6652339-1 1983 In vivo clorgyline (5 mg/kg) and (-)-deprenyl (5 mg/kg) selectively inhibit monoamine oxidase (MAO) type A and B activities in rat brain hypothalamus and caudate nucleus using 5-hydroxytryptamine (5-HT), noradrenaline (NA), and beta-phenylethylamine (PEA) as substrates. phenethylamine 228-249 monoamine oxidase A Rattus norvegicus 76-112 6652339-1 1983 In vivo clorgyline (5 mg/kg) and (-)-deprenyl (5 mg/kg) selectively inhibit monoamine oxidase (MAO) type A and B activities in rat brain hypothalamus and caudate nucleus using 5-hydroxytryptamine (5-HT), noradrenaline (NA), and beta-phenylethylamine (PEA) as substrates. phenethylamine 251-254 monoamine oxidase A Rattus norvegicus 76-112 6797482-3 1981 After solubilization of MAO by methylethylketone 7% of mitochondrial activity passes into solution and the rate of deamination of serotonin, tyramine and beta-phenylethylamine by soluble MAO preparation is selectively decreased. phenethylamine 154-175 monoamine oxidase A Rattus norvegicus 24-27 6401800-9 1983 H2O2 generated by deamination of NA or PEA by MAO, or during the enzymatic oxidation of glucose by GOD, caused a threefold increase in mitochondrial endoperoxide formation. phenethylamine 39-42 monoamine oxidase A Rattus norvegicus 46-49 6884911-1 1983 The inhibiting effect of monoamine oxidase (MAO) activities towards 5-hydroxytryptamine, dopamine and beta-phenylethylamine by an acute and chronic administration of clorgyline was investigated in five locations of the rat brain. phenethylamine 102-123 monoamine oxidase A Rattus norvegicus 25-42 6884911-1 1983 The inhibiting effect of monoamine oxidase (MAO) activities towards 5-hydroxytryptamine, dopamine and beta-phenylethylamine by an acute and chronic administration of clorgyline was investigated in five locations of the rat brain. phenethylamine 102-123 monoamine oxidase A Rattus norvegicus 44-47 6884911-3 1983 A significant percentage of inhibition for type B MAO towards beta-phenylethylamine was noticed in the chronically administered group. phenethylamine 62-83 monoamine oxidase A Rattus norvegicus 50-53 7080482-8 1982 Controlled heating experiments indicated higher thermostability of MAO type B (substrate: 2-phenylethylamine) as compared with MAO type A (substrate: serotonin) in rat intestinal mitochondria. phenethylamine 90-108 monoamine oxidase A Rattus norvegicus 67-70 6807318-3 1982 In contrast, B-form MAO activity decreased rapidly and the level of MAO activity was maintained at about 30% with beta-phenylethylamine (beta-PEA) as substrate. phenethylamine 114-135 monoamine oxidase A Rattus norvegicus 20-23 6807318-3 1982 In contrast, B-form MAO activity decreased rapidly and the level of MAO activity was maintained at about 30% with beta-phenylethylamine (beta-PEA) as substrate. phenethylamine 114-135 monoamine oxidase A Rattus norvegicus 68-71 6807318-3 1982 In contrast, B-form MAO activity decreased rapidly and the level of MAO activity was maintained at about 30% with beta-phenylethylamine (beta-PEA) as substrate. phenethylamine 137-145 monoamine oxidase A Rattus norvegicus 20-23 6807318-3 1982 In contrast, B-form MAO activity decreased rapidly and the level of MAO activity was maintained at about 30% with beta-phenylethylamine (beta-PEA) as substrate. phenethylamine 137-145 monoamine oxidase A Rattus norvegicus 68-71 6797482-3 1981 After solubilization of MAO by methylethylketone 7% of mitochondrial activity passes into solution and the rate of deamination of serotonin, tyramine and beta-phenylethylamine by soluble MAO preparation is selectively decreased. phenethylamine 154-175 monoamine oxidase A Rattus norvegicus 187-190 6797482-8 1981 The rate of inhibition by deprenyl of beta-phenylethylamine oxidation due to MAO solubilization by methylethylketone is not changed. phenethylamine 38-59 monoamine oxidase A Rattus norvegicus 77-80 6107935-0 1980 Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue. phenethylamine 133-154 monoamine oxidase A Rattus norvegicus 97-100 7264651-1 1981 The inhibiton of type A and B MAO in rat forebrain crude membrane preparation by MD780515, (3-(4-[(3-cyanophenyl)methoxy]phenyl)-5-(methoxymethyl)-2-oxazolidinone-Centre de Recherche Delalande, France) has been investigated in vitro with 5-hydroxytryptamine and beta-phenylethylamine as substrates. phenethylamine 262-283 monoamine oxidase A Rattus norvegicus 30-33 7205271-1 1981 beta-Phenylethylamine (PEA) was characterized as a substrate for type A and type B monoamine oxidase (MAO) in brain and liver mitochondria of eight species at different substrate concentrations. phenethylamine 0-21 monoamine oxidase A Rattus norvegicus 102-105 7205271-1 1981 beta-Phenylethylamine (PEA) was characterized as a substrate for type A and type B monoamine oxidase (MAO) in brain and liver mitochondria of eight species at different substrate concentrations. phenethylamine 23-26 monoamine oxidase A Rattus norvegicus 102-105 435561-5 1979 In analogous experiments with deprenyl (the specific inhibitor of MAO type B) 4-ethylpyridine (5.10(-3) M) decreased the inhibitory effect of deprenyl not only on the deamination of serotonin (substrate of MAO A), but also on the oxidation of beta-phenylethylamine (the main substrate of MAO type B). phenethylamine 243-264 monoamine oxidase A Rattus norvegicus 66-69 435561-1 1979 The inhibition of the deamination of serotonin (the main substrate of monoamine oxidase (MAO) type A) by chlorgiline and deprenyl and of beta-phenylethylamine (the main substrate of the B type MAO) by fragments of rat liver mitochondrial membrane as well as the influence of 4-ethylpyridine on this process were studied. phenethylamine 137-158 monoamine oxidase A Rattus norvegicus 89-92 435561-2 1979 It was shown that the MAO activity of the mitochondrial membrane fragments was highly sensitive to chlorgiline, when serotonin was used as substrate, whereas a high sensitivity toward deprenyl was observed with beta-phenylethylamine as substrate. phenethylamine 211-232 monoamine oxidase A Rattus norvegicus 22-25 435561-3 1979 4-Ethylpyridine (5.10(-3) M), a competitive and reversible inhibitor of the MAO activity, inhibited deamination of serotonin and beta-phenylethylamine by 34 and 30%, respectively. phenethylamine 129-150 monoamine oxidase A Rattus norvegicus 76-79 32944-1 1979 1 Metabolism of 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PHE) by monoamine oxidase (MAO) was investigated in rat isolated lungs and in mitochondrial preparations from rat lung. phenethylamine 47-68 monoamine oxidase A Rattus norvegicus 78-95 32944-1 1979 1 Metabolism of 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PHE) by monoamine oxidase (MAO) was investigated in rat isolated lungs and in mitochondrial preparations from rat lung. phenethylamine 47-68 monoamine oxidase A Rattus norvegicus 97-100 32944-1 1979 1 Metabolism of 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PHE) by monoamine oxidase (MAO) was investigated in rat isolated lungs and in mitochondrial preparations from rat lung. phenethylamine 70-73 monoamine oxidase A Rattus norvegicus 78-95 32944-1 1979 1 Metabolism of 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PHE) by monoamine oxidase (MAO) was investigated in rat isolated lungs and in mitochondrial preparations from rat lung. phenethylamine 70-73 monoamine oxidase A Rattus norvegicus 97-100 490150-7 1979 Pineal monoamine oxidase (MAO) activity type B (assaying by using beta-phenylethylamine as substrate) was decreased by FSH or LH injection. phenethylamine 66-87 monoamine oxidase A Rattus norvegicus 7-24 490150-7 1979 Pineal monoamine oxidase (MAO) activity type B (assaying by using beta-phenylethylamine as substrate) was decreased by FSH or LH injection. phenethylamine 66-87 monoamine oxidase A Rattus norvegicus 26-29 711033-2 1978 The rates of serotonin, beta-phenylethylamine and benzylamine oxidations by placental MAO were approximately 191, 12 and 48% to those of rat liver MAO, respectively. phenethylamine 24-45 monoamine oxidase A Rattus norvegicus 86-89 1241962-6 1975 l-Deprenyl but not clorgyline (2 or 8 mg/kg s.c.) potentiated the stereotyped sniffing behaviour induced by beta-phenylethylamine, a specific substrate for type B monoamine oxidase. phenethylamine 108-129 monoamine oxidase A Rattus norvegicus 163-180 887501-4 1977 Deprenyl is a selective inhibitor of the "B form" of MAO, which preferentially oxidizes beta-phenylethylamine as substrate. phenethylamine 88-109 monoamine oxidase A Rattus norvegicus 53-56 934359-1 1976 The effect of graded doses of clorgyline, a preferential inhibitor of MAO A, and of deprenil, a preferential inhibitor of MAO B, on the activities of serotonin-deaminating MAO (MAO A) of dopamine-deaminating MAO, and of phenethylamine-deaminating MAO, (MAO B), in rat corpus striatum were compared with the effects of the drugs on striatal levels of homovanillic acid(HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC). phenethylamine 220-234 monoamine oxidase A Rattus norvegicus 177-182 595495-3 1977 Interaction of N-(8-quinolylmethyl)-N-methyl-2-propinyl amine with MAO of the A type (serotonin as a substrate) and of the B type (beta-phenylethylamine as a substrate) was studied by the kinetic method, which enabled to determine and quantitatively estimate the steps of enzyme-inhibitor complexes formation. phenethylamine 131-152 monoamine oxidase A Rattus norvegicus 67-70 595495-5 1977 The data on K1 values, estimated in experiments with serotonin and beta-phenylethylamine as substrates, show that the affinity of N-(8-quinolyl methyl)-N-methyl-2-propinyl amine towards MAO of the A type was 10-fold higher than the affinity towards MAO of the B type. phenethylamine 67-88 monoamine oxidase A Rattus norvegicus 186-189 595495-5 1977 The data on K1 values, estimated in experiments with serotonin and beta-phenylethylamine as substrates, show that the affinity of N-(8-quinolyl methyl)-N-methyl-2-propinyl amine towards MAO of the A type was 10-fold higher than the affinity towards MAO of the B type. phenethylamine 67-88 monoamine oxidase A Rattus norvegicus 249-252 956156-1 1976 A simple fluorometric assay for monoamine oxidase (MAO) [EC 1.4.3.4] activity towards beta-phenylethylamine (PEA) was devised. phenethylamine 86-107 monoamine oxidase A Rattus norvegicus 32-49 956156-1 1976 A simple fluorometric assay for monoamine oxidase (MAO) [EC 1.4.3.4] activity towards beta-phenylethylamine (PEA) was devised. phenethylamine 86-107 monoamine oxidase A Rattus norvegicus 51-54 956156-1 1976 A simple fluorometric assay for monoamine oxidase (MAO) [EC 1.4.3.4] activity towards beta-phenylethylamine (PEA) was devised. phenethylamine 109-112 monoamine oxidase A Rattus norvegicus 32-49 956156-1 1976 A simple fluorometric assay for monoamine oxidase (MAO) [EC 1.4.3.4] activity towards beta-phenylethylamine (PEA) was devised. phenethylamine 109-112 monoamine oxidase A Rattus norvegicus 51-54 1248576-1 1976 The distribution of type A and B monamine oxidase (MAO) activities in the central nervous system (CNS) of rat and chick was investigated using 5-hydroxytryptamine and beta-phenylethylamine as specific substrates. phenethylamine 167-188 monoamine oxidase A Rattus norvegicus 51-54